SOLV Stock: Price, Earnings History and SEC Filings
Solventum Corporation (SOLV) last traded at $81.33, down 2.67% on the latest session and down 7.7% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $2.55 against an analyst estimate of $1.91, a beat of 33.5%.
$81.33 -2.67%
1 month-7.74%
52-week high$94.16
52-week low$62.38
Volume1.07M
ExchangeNYSE
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
SOLV earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | Aug 5, 2026 | $2.55 | $1.91 | +33.51% |
| Mar 2026 | May 5, 2026 | $1.48 | $1.35 | +9.63% |
| Dec 2025 | Feb 26, 2026 | $1.57 | $1.50 | +4.67% |
| Sep 2025 | Nov 6, 2025 | $1.50 | $1.43 | +4.90% |
SOLV beat the analyst EPS estimate in 4 of its last 4 reported quarters. Source: Nasdaq.
Latest SEC filings for SOLV
SEC filing data is not available right now. You can search for SOLV on SEC EDGAR.
SOLV news
- Solventum Corp.Oct 31, 2026 · 247wallst.com
- Solventum (SOLV) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 ReleaseOct 29, 2026 · finance.yahoo.com
- Should Steris Stock Holders Look At Medtronic Instead?Oct 29, 2026 · trefis.com
- Here's why Solventum (SOLV) is a strong value stockOct 29, 2026 · msn.com
- Solventum’s Quarterly Earnings Preview: What You Need to KnowOct 27, 2026 · barchart.com
- 2 cash-burning stocks for long-term investors and 1 we turn downOct 23, 2026 · finance.yahoo.com
- SOLV Wins FDA Clearance to Combine Restrata Matrix With V.A.C.TherapyOct 23, 2026 · finance.yahoo.com
- Mexico Prefabricated Crown and Bridge Materials Market Outlook to 2036: Permanent Crowns and Bridges Revenue, Volume and PricingOct 22, 2026 · finance.yahoo.com
About Solventum Corporation
Solventum Corporation (SOLV) is a US-listed public company on NYSE.